Evidence map›Paper›PMID 36239724›Full record

ArticleCurrent diabetes reviews2025

Prevalence and Predictors of Albuminuria in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study from the United Arab Emirates.

Moza Saleh Hassan Almukhattin, Suhaj Abdulsalim, Suhaila Mohammed Shareef Alawadhi, Mirza R Baig, Sonal Sekhar Miraj, Noufal Abdulkader

Abstract read
PubMed Publisher
In one paragraph

Article in Current diabetes reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

Moza Saleh Hassan AlmukhattinEmirates Health Services, Dubai, United Arab Emirates.
Suhaj AbdulsalimDepartment of Pharmacy Practice, Unaizah College of Pharmacy, Buraidah, Qassim University, Saudi Arabia.
Suhaila Mohammed Shareef AlawadhiMinistry of Health and Prevention, Dubai, United Arab Emirates.
Mirza R BaigDepartment of Clinical Pharmacy, Dubai Pharmacy College for Girls, Dubai, United Arab Emirates.
Sonal Sekhar MirajDepartment of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, India.
Noufal AbdulkaderEmirates Health Services, Dubai, United Arab Emirates.
Abu Dhabi Health Services · AEDubai Pharmacy College · AEManipal Academy of Higher Education · INMinistry of Health · AEQassim University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

introductionAlbuminuria in Diabetes mellitus (DM) patients may lead to nephropathy and end-stage renal disease. Our study aimed to assess the prevalence of albuminuria and its associated predictors among type 2 DM patients in the United Arab Emirates.

methodsA retrospective cross-sectional study was conducted among type 2 DM patients in the diabetic clinic at Fujairah Hospital from 1st January 2016 to 30th January 2020 after getting the ethical clearance. Data were collected electronically from the health information system and analyzed using SPSS version 26. Regression analysis and ANOVA were used for inferential analysis. A P-value of ≤0.05 was considered significant. RESULTS AND DISCUSSION: Among the 200 patients included in the study, the mean age of the study population was 56 years, and the majority of them were females (71%). The prevalence of albuminuria was found to be 44%. By using regression analysis, glycated hemoglobin (HbA1c; P=0.038) and systolic blood pressure (SBP; P=0.003) were found to be predictors of albuminuria. One way ANOVA revealed that there were significant associations between the albumin levels and HbA1c (P=0.004), SBP (P= 0.002), diastolic blood pressure (DBP; P=0.028), serum creatinine (Scr) (P=0.039), and glomerular filtration rate (GFR; P=0.013).

conclusionTo the best of our knowledge, this is the first study from Fujairah emirate that explored the prevalence and predictors of albuminuria in type 2 DM patients. We found a high prevalence of albuminuria among type 2 DM patients. HbA1c and SBP directly contributed to albuminuria. To improve glycemic control, patients need to improve physical activity, reduce overweight and, adherence to medications that improve overall therapeutic outcomes.

Indexed as

AlbuminuriaDiabetes Mellitus, Type 2Diabetic NephropathiesAdultAgedBlood PressureCross-Sectional StudiesFemaleGlycated HemoglobinHumansMaleMiddle AgedPrevalenceRetrospective StudiesRisk FactorsUnited Arab EmiratesGlycated Hemoglobinhemoglobin A1c protein, humanAlbuminuriaend-stage renal diseasehemoglobin A1cnephropathysystolic blood pressure.type 2 diabetes

Identifiers

PMID36239724
OpenAlexW4306178323

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.